Citi on Hims and Hers (HIMS): 'Will Enter the Canadian Market in 2026 as Generic Semaglutide Looms' Jul 9, 2025 10:26AM
Citi on Hims and Hers (HIMS): 'If HIMS does end up partnering with LLY, in our view it would signal that HIMS is “throwing in the towel” on compounded GLP-1s' Jun 10, 2025 03:25PM
Citi Reiterates Sell Rating on Hims and Hers (HIMS), PT $30 Jun 3, 2025 09:20AM
Citi Drops Third Note on Hims and Hers (HIMS) Inside 20 Hours: 'HIMS is now offering discounts on its bundles, effectively passing through the price discount' May 22, 2025 02:52PM
Citi Reiterates Sell Rating on Hims and Hers (HIMS), Comments on Novo's Wegovy Price Promo: 'We see this as another potential headwind for HIMS May 22, 2025 11:34AM


May 22, 2025 09:49AM Hims & Hers Health: Analysts remain bearish
May 22, 2025 04:56AM Citi Reiterates Sell Rating on Hims and Hers (HIMS), PT $30, 'we do think that this will be a slight headwind to HIMS'
Apr 29, 2025 08:32AM Citi Reiterates Sell Rating on Hims and Hers (HIMS), 'We think HIMS will not make any margin on dispensing of Wegovy'
Apr 25, 2025 05:13AM Hims and Hers (HIMS) PT Lowered to $25 at Citi Amid Valuation Destruction During 2025
Mar 10, 2025 03:14PM Citi Reiterates Sell Rating on Hims and Hers (HIMS), PT $27, 'highly unlikely that this appeal changes much'
Mar 6, 2025 08:29AM Citi Reiterates Sell Rating on Hims and Hers (HIMS), PT $27, 'Court Delivers Another Blow to Tirzepatide Compounders'
Mar 5, 2025 09:41AM Citi Reiterates Sell Rating on Hims and Hers (HIMS), PT $27, 'We view this as Novo taking a direct shot at HIMS'
Feb 25, 2025 04:58AM Hims and Hers (HIMS) PT Raised to $27 at Citi, Maintains Sell 'as we await a better entry point and more details on growth outside GLP-1s'
Jan 10, 2025 05:15AM Citi Downgrades Hims and Hers (HIMS) to Sell
Nov 5, 2024 06:31AM Hims and Hers (HIMS) PT Raised to $24 at Citi
Oct 3, 2024 07:37AM Citi Reiterates Neutral Rating on Hims and Hers (HIMS)
Aug 27, 2024 08:24AM Citi on Hims and Hers (HIMS) Post Lilly (LLY) News: 'Single-dose Zepbound Vials a Shot Across the Bow for the Compounders'
Jul 22, 2024 04:30AM These stocks are near-term opportunity to invest in the GLP-1 space
May 22, 2024 02:35AM Citi Downgrades Hims and Hers (HIMS) to Neutral
May 20, 2024 11:49AM Citi Reiterates Buy Rating on Hims and Hers (HIMS)
Dec 4, 2023 11:41AM Citi Comments on Hims and Hers (HIMS) Weight Loss Program
Feb 6, 2023 09:00AM Hims & Hers to Announce Fourth Quarter and Full Year 2022 Financial Results on February 27, 2023
Feb 23, 2022 04:06PM Hims & Hers Health, Inc. to Participate at Citi’s 2022 Virtual Healthcare Conference
Sep 9, 2021 04:01PM Hims & Hers Health to Present at Upcoming Financial Conferences
Feb 17, 2021 04:05PM Hims & Hers Health, Inc. to Participate in Upcoming Investor Conference
Jan 21, 2021 09:25AM Hims & Hers Health (HIMS) Starts Trading on NYSE Following Completion of SPAC Merger